There is very limited published data describing medicinal uses of Portunus extract. A recent report describes the identification of a glycosaminoglycan extracted from Portunus pelagicus as an inhibitor of ÎČ-secretase 1 (BACE), which plays a role in the pathogenesis of Alzheimer's Disease. 11 However, to our knowledge, there are no publications describing anti-cancer properties of Portunus extract. Data from the International Agency for Research on Cancer indicates there were 17 million new cases of cancer worldwide in 2018, with this projected to increase to 27.5 million new cases per year by 2040, if recent trends continue. 12 The most common cancers in 2018 were breast, prostate, lung and colorectal. Cutaneous melanoma was the 19th most common cancer worldwide in 2018 but shows significant variation in incidence rates across ethnic groups, with fair skinned people the most affected. 13 Melanoma is also one of the most common cancers in young adults and as such, is responsible for many years of life lost per death. Australia and New Zealand have the highest incidence of melanoma with 15,229 new diagnosed cases predicted in 2019. 14 Until 2011, the main treatment of metastatic melanoma was dacarbazine, which showed limited efficacy. 15 Since then, the Food and Drug administration (FDA) has approved immunotherapies, targeted therapies and an oncolytic virus for treatment of melanoma. 16 However, these therapies can have significant side effects, and in the case of targeted therapies (such as BRAF inhibitors), patients often acquire resistance within months, limiting their clinical use. 16 Thus, the identification and development of new therapeutic options for melanoma remains a priority. In this study, the melanoma cell line SK-MEL-28 cell line was treated with Portunus extracts, derived from whole crab ash (CA), shell, and muscle fibers, at different concentrations. CA ethanol extract had the greatest effect on cell proliferation, with 50% cell death after 24 hours at 1250 ”g/mL. SK-MEL-28 cells were then treated with a sub-lethal concentration of CA ethanol extract (750 ”g/mL, 24 hours) and cell lysates subjected to proteome analysis. Compared to control cells, cells